ASELAGE STEVE - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 12, 2024, ASELAGE STEVE's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Director, and currently has 70,159 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BCRX insiders.
Data Source: SEC.
ASELAGE STEVE - Insider Non-Derivative Transactions of BCRX Common Stock
ASELAGE STEVE - Insider Non-Derivative Transactions at BCRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 13, 2024 | Acquisition -- (Common Stock) | 6820 | 0 | 70159 |
| May 25, 2024 | P -- (Common Stock) | 2500 | 6.4 | 2500 |
| Jun 14, 2023 | Acquisition -- (Common Stock) | 16745 | 0 | 63339 |